{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:25:12Z","timestamp":1767824712821,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.drugalcdep.2013.01.016","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T11:44:33Z","timestamp":1361533473000},"page":"122-126","source":"Crossref","is-referenced-by-count":24,"title":["Use of naltrexone for alcohol use disorders in the Veterans\u2019 Health Administration: A national study"],"prefix":"10.1016","volume":"132","author":[{"given":"Theddeus","family":"Iheanacho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Marienfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Rosenheck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0005","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.281.14.1318","article-title":"Pharmacological treatment of alcohol dependence: a review of the evidence","volume":"281","author":"Garbutt","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2004.02.004","article-title":"The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991\u20131992 and 2001\u20132002","volume":"74","author":"Grant","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0015","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1176\/ps.2010.61.4.392","article-title":"Pharmacotherapy of alcohol use disorders in the Veterans Health Administration","volume":"61","author":"Harris","year":"2010","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1176\/appi.ps.55.3.221","article-title":"Datapoints: trends in naltrexone use among members of a large private health plan","volume":"55","author":"Harris","year":"2004","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.300.6.663","article-title":"Alcohol use and alcohol-related problems before and after military combat deployment","volume":"300","author":"Jacobson","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","article-title":"Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study","volume":"60","author":"Kiefer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0035","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMoa011127","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"345","author":"Krystal","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/alcalc\/agm136","article-title":"A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence","volume":"43","author":"Laaksonen","year":"2008","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0376-8716(03)00134-0","article-title":"Understanding US addiction physicians\u2019 low rate of naltrexone prescription","volume":"71","author":"Mark","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1360-0443.2006.01310.x","article-title":"Rates and predictors of relapse after natural and treated remission from alcohol use disorders","volume":"101","author":"Moos","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0055","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1360-0443.2006.01555.x","article-title":"Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial","volume":"101","author":"Morley","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0060","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/01.ALC.0000095861.43232.19","article-title":"Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs","volume":"27","author":"Petrakis","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0065","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/schbul\/sbl010","article-title":"Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram","volume":"32","author":"Petrakis","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-003-1658-9","article-title":"Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia","volume":"172","author":"Petrakis","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0075","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.biopsych.2006.03.074","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder","volume":"60","author":"Petrakis","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0080","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.biopsych.2005.02.016","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders","volume":"57","author":"Petrakis","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0085","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/01.jcp.0000245566.52401.20","article-title":"The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking","volume":"26","author":"Pettinati","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0090","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0095","first-page":"CD001867","article-title":"Opioid antagonists for alcohol dependence","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0100","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2105\/AJPH.2008.150284","article-title":"Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002\u20132008","volume":"99","author":"Seal","year":"2009","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0105","first-page":"1","article-title":"Pharmacotherapy for alcohol dependence","author":"West","year":"1999","journal-title":"Evid. Rep. Technol. Assess. (Summ.)"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0110","first-page":"1775","article-title":"Medications for treating alcohol dependence","volume":"72","author":"Williams","year":"2005","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/TCRM.S23184","article-title":"Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility","volume":"8","author":"Witkiewitz","year":"2012","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.drugalcdep.2013.01.016_bib0120","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archpsyc.65.10.1214","article-title":"Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients","volume":"65","author":"Zarkin","year":"2008","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161300029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161300029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T13:30:17Z","timestamp":1539869417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161300029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S037687161300029X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.01.016","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}